Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 1

Внебольничная пневмония: возможности диагностики, лечения и вакцинопрофилактики в условиях пандемии COVID-19
А.А. Зайцев

References

1. Ministry of Healthcare of the RF; Russian Respiratory Society; Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy. Clinical recommendations. Community-acquired pneumonia. ICD-10: J13-J18. 2018. Available from: http://www.antibiotic.ru/files/pdf/2018/vp2018-project.pdf Accessed 2020 Aug 05. (In Russian).
2. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 2007 Mar;44(Suppl 2):S27-72.
3. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJM; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections – full version. Clinical Microbiology and Infection 2011 Nov;17(Suppl 6):E1-59.
4. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clinical Infectious Diseases 2010 Jan;50(2):202-9.
5. Quah J, Jiang B, Tan P, Siau C, Tan TY. Impact of microbial aetiology on mortality in severe community-acquired pneumonia. BMC. Infectious Diseases 2018 Sep;18(1):451.
6. Zaytsev AA, Shchegolev AV. Diagnostics and treatment of severe lung lesions in influenza A(H1N1/09): practical guidelines. The Military Medical Journal 2016;337(3):39-46 (In Russian).
7. Zaytsev AA. COVID-19, discussion: changes in lungs caused by coronavirus, and treatment approaches. Information letter from Interregional Association of Respiratory Medicine Specialists. Available from: http://www.antibiotic.ru/index.php?article=2959 Accessed 2020 Aug 05 (In Russian).
8. Zaytsev AA, Chernov SA, Kryukov EV, Golukhova EZ, Rybka MM. Managing patients with novel coronavirus infection (COVID-19) in hospital (preliminary results and recommendations). Lechashchiy Vrach 2020;6:74-9 (In Russian).
9. Ministry of Healthcare of the RF. Prevention, diagnosis, and treatment of novel coronavirus infection (COVID-19): provisional guidelines. Version 7 dated 2020 Jun 03. Moscow, 2020. 166 p. (In Russian).
10. Burdenko NN Main Military Clinical Hospital. Algorithms for managing patients with novel coronavirus infection (COVID-19) in hospital. Methodological recommendations. Moscow, 2020. 16 p. (In Russian).
11. Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020;395:507-13.
12. Guan W, Ni Z, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 2020;382:1708-20.
13. Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, Kouatchet A, Mourvillier B, Dellamonica J, Picard W, Schmidt M, Boulain T, Brun-Buisson C; A/H1N1 REVA-SRLF Study Group. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Medicine 2011 May;37(5):796-800.
14. Rhee J-Y, Hong G, Ryu KM. Clinical implications of 5 cases of Middle East respiratory syndrome coronavirus infection in a South Korean outbreak. Japanese Journal of Infectious Disease 2016;69(5):361-6.
15. Russian Respiratory Society; National Association of Specialists for Control of Healthcare-associated Infections. Federal clinical guidelines for prevention of pneumococcal infection in adults. Russian Pulmonology 2019;29(1):19-34 (In Russian).
16. European Centre for Disease Prevention and Control. Invasive pneumococcal disease – Annual epidemiological report for 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/invasive-pneumococcal-disease-annual-epidemiological-report-2016 Accessed 2020 Aug 05.
17. Muravyev AA. Scientific report of Antimicrobial Chemotherapy Research Institute in Smolensk State Medical University: presented at online Scientific Conference "Respiratory School"; 2020 May 30. (In Russian).
18. Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report 2019 Nov;68(19):1069-75.
19. Tenitskiy AF, Skipin MV, Zaytsev AA. Community-acquired pneumonia in people at increased risk of severe illness. The Military Medical Journal 2004;6:61 (In Russian).
20. Kozlov RS, Avdeyev SN, Briko NI, Bilichenko TN, Kostinov MP, Sidorenko SV, Kharit SM, Sinopalnikov AI, Zaytsev AA, Shubin IV, Demko IV, Ignatova GL, Rachina SA, Feldblum IV. Pneumococcal vaccination in adults. Resolution of the Council of Experts (Moscow, December 16, 2017). Clinical Microbiology and Antimicrobial Chemotherapy 2018;20(1):5-8 (In Russian).
21. NIH. US National Library of Medicine. Post-Exposure Prophylaxis/preemptive therapy for SARS-Coronavirus-2 (COVID-19 PEP). Available from: https://clinicaltrials.gov/ct2/show/NCT04308668 Accessed 2020 Aug 05.
22. Mitjà O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. The Lancet. Global Health 2020 May;8(5):e639-40.
23. CDC. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Clinical questions about COVID-19: questions and answers. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html Accessed 2020 Aug 05.
24. Military Medical Administration of the Ministry of Defense. Diagnosis, treatment, and prevention of novel coronavirus infection (COVID-19). Guidelines. Moscow, 2020. 50 p. (In Russian).
25. Van Boeckel T, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, Teillant A, Laxminarayan R. Global trends in antimicrobial use in food animals. Proceedings of National Academy of Sciences of the USA 2015 May;112(18):5649-54.
26. Review on Antimicrobial Resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance, chaired by O’Neill J. 2014 Dec. Available from: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf Accessed 2020 Aug 05.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]